C. D. Mahle

发表

Melatonin receptors: potential targets for central nervous system disorders.

C. D. Mahle, A. Watson, A. J. Watson, 1997, Expert opinion on investigational drugs.

Chapter 4. Melatonin Receptor Ligands and Their Potential Clinical Applications

C. D. Mahle, A. Watson, K. Takaki, 1997 .

Effect of exercise on glycolytic enzymes of zucker fatty rats

C. D. Mahle, G. A. Tejwani, S. Hanissian, 1988, Molecular and Cellular Biochemistry.

Mono- and diacylglycerol lipases in spinal cord of lean and obese Zucker rats.

L. Horrocks, A. A. Farooqui, C. D. Mahle, 1987, Comparative biochemistry and physiology. B, Comparative biochemistry.

Age-dependence of effects of A1 adenosine receptor antagonism in rat hippocampal slices.

V. Gribkoff, C. D. Mahle, C. Boissard, 1992, Journal of neurophysiology.

A Novel Long-Acting Selective Neuropeptide Y 2 Receptor PEGylated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents

Astrid A. Ortiz, K. Lumb, J. Livingston, 2007 .

A Novel Long-Acting Selective Neuropeptide Y2 Receptor Polyethylene Glycol-Conjugated Peptide Agonist Reduces Food Intake and Body Weight and Improves Glucose Metabolism in Rodents

Astrid A. Ortiz, K. Lumb, J. Livingston, 2007, Journal of Pharmacology and Experimental Therapeutics.

Bivalent indoles exhibiting serotonergic binding affinity

R. Mattson, C. D. Mahle, A. Gentile, 1995 .

Cloning and characterization of the rat 5‐HT5B receptor

P. Seeburg, W. Wisden, P. Seeburg, 1993, FEBS letters.

Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides.

Astrid A. Ortiz, R. Mattson, M. Parker, 2004, Bioorganic & medicinal chemistry.

Bivalent Indoles Exhibiting Serotonergic Binding Affinity.

R. Mattson, C. D. Mahle, A. Gentile, 1995 .

(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.

S. Bertenshaw, C. D. Mahle, K. Takaki, 2005, Bioorganic & medicinal chemistry letters.

Indanyl piperazines as melatonergic MT2 selective agents.

R. Mattson, C. D. Mahle, F. Yocca, 2003, Bioorganic & medicinal chemistry letters.

Reduced bicuculline response and GABAA agonist binding in aged rat hippocampus

V. Gribkoff, J. T. Lum-Ragan, D. Post‐Munson, 1994, Neurobiology of Aging.

N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.

Jie Chen, C. D. Mahle, K. Takaki, 2004, Bioorganic & medicinal chemistry letters.

Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.

C. D. Mahle, K. Takaki, Cen Xu, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.

C. D. Mahle, K. Takaki, Cen Xu, 2004, Bioorganic & medicinal chemistry letters.

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor.

J. Gusella, S. Reppert, D. Weaver, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells.

E. Parker, C. D. Mahle, L. Iben, 1995, Brain research. Molecular brain research.

Cloning of a melatonin‐related receptor from human pituitary

L. F. Kolakowski, S. Reppert, D. Weaver, 1996, FEBS letters.

Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.

G. Sutherland, K. Dickinson, C. D. Mahle, 1998, Brain research. Molecular brain research.

N‐{2‐[2‐(4‐Phenylbutyl)benzofuran‐4‐yl]cyclopropylmethyl}acetamide: An Orally Bioavailable Melatonin Receptor Agonist.

C. D. Mahle, K. Takaki, J. Knipe, 2005 .

Melatonin Modulates Vascular Smooth Muscle Tone

C. D. Mahle, A. Watson, Puja Agarwal, 1997, Journal of biological rhythms.

Characterization of human 5-HT1 receptors expressed in Sf9 insect cells.

E. Parker, C. D. Mahle, F. Yocca, 1994, European journal of pharmacology.

Development of a presynaptic 5-HT1A antagonist.

R. B. Carter, R. Mattson, C. D. Mahle, 2003, Bioorganic & medicinal chemistry letters.

Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.

Astrid A. Ortiz, K. Lumb, L. Decarr, 2007, Journal of medicinal chemistry.

Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.

J. Zgombick, C. D. Mahle, S. Beck, 1989, Molecular pharmacology.

Differential sensitivity of 3H‐agonist binding to pre‐ and postsynaptic 5‐HT1A receptors in bovine brain

C. D. Mahle, F. Yocca, L. Iben, 1994, British journal of pharmacology.

[3H]‐5‐carboxamidotryptamine labels 5‐HT1D binding sites in bovine substantia nigra

C. D. Mahle, F. Yocca, H. Nowak, 1993, British Journal of Pharmacology.

[3H]5-carboxamidotryptamine labels multiple high affinity 5-HT1D-like sites in guinea pig brain.

R. Mattson, C. D. Mahle, F. Yocca, 1991, European journal of pharmacology.